This year, the Charing Cross Symposium is launching the CX Live Case method. Thomas Zeller (Universitäts-Herzzentrum Freiburg – Bad Krozingen, Bad Krozingen, Germany), course director of the CX Live Peripheral Arterial Cases, will link the live case demonstrations from Bad Krozingen with topics to be discussed in the CX Main Programme – Peripheral Arterial Controversies at the Charing Cross Symposium 2015.
Starting with shorter and simpler lesions, Zeller and his team will aim to demonstrate the value of drug-coated balloons against plain old balloon angioplasty. Beyond this, longer and also calcified arterial stenoses will be tackled. The audience will see which stents are selected, and whether atherectomy pre-stent is thought to be beneficial. Zeller will show which stent devices can reach longer lesions and into the popliteal artery, and which require pre-treatment with adjunctive therapies. The value of drug-eluting stents will also be demonstrated, and the management of in-stent restenosis and its correction by mechanical means will be shown.
In this interview, he explains the value of live case presentations at conferences and the importance of relating the CX Live Peripheral Arterial Cases to the topics of the CX Main Programme – Peripheral Arterial Controversies, and encourages audience interaction in this session.
What are the benefits of including live case presentations in medical conferences?
Live case presentations—provided they are unbiased—support the transfer of clinical science into clinical practice. New technologies and treatment algorithms can be demonstrated (supplementing talks and roundtable discussions) and the potential limitations and advantages in daily routine can be highlighted. With live case presentations; conference audience gets a better and practical impression of how new technologies can be implemented in the interventionalist’s routine.
What are the benefits of having the CX Live Peripheral Arterial Cases relate to what is discussed in the CX Main Programme – Peripheral Arterial Controversies?
The attendee gets immediate insights into the clinical application and potential pitfalls of new interventional strategies, which have been discussed in the CX Main Peripheral Programme (The CX Main Programme – Peripheral Arterial Controversies will take place on 28 April 2015, a day before the CX Live Peripheral Arterial Cases). Every new technology imposes a learning curve which might become shortened if the attendee gets advice from experienced operators who have already gained experience in the application of interventional strategies or use of those new technologies.
The live cases for the Charing Cross Symposium have been selected based on the topic of a given session to enable the panel and audience to discuss these topics with the operators.
The CX Main Programme – Peripheral Arterial Controversies dedicates a session to the discussion of revascularisation strategies in the superficial femoral artery; which key controversies will you try to shed light on with the CX Live Peripheral Arterial Cases session in this field?
In the CX Peripheral Live Cases, the main issue of controversy to discuss is the potential role of drug-coated balloons and drug-eluting stents for the treatment of the superficial femoral artery. We will analyse whether (or not) these devices are worth the costs compared to standard treatment (plain old balloon angioplasty and bare metal stenting). Moreover, the role of spot stenting in a drug-coated balloon setting will be discussed and finally the potential role of vessel preparation prior to the use of drug-eluting technologies.
What techniques and technologies will be demonstrated at the CX Live Peripheral Arterial Cases session?
We will show interventions dealing with drug-coated balloons and provisional stenting, stenting of kink zones, vessel preparation with debulking devices, how to treat in-stent reocclusions, etc.
The CX Symposium advocates strong audience interaction; how will you encourage participants’ interaction in the CX Live Peripheral Arterial Cases session?
Audience interaction has to be pushed by the moderators and panellists. We as operators will be open to questions from the audience and we will also invite the audience to express their own experiences with the interventional techniques, which will be shown during the live case transmissions.
The CX Live Peripheral Arterial Cases session will take place at the Charing Cross Symposium on Wednesday 29 April – Grey Learning Centre, Olympia Grand, London, UK
Click here to see the CX Main Programme Sessions
Click here to see the CX Parallel Sessions
Click here to register